BioSpace News Archive

Applied Molecular Transport (Nasdaq: AMTI), a clinical-stage biopharmaceutical company, today announced the pricing of its initial public offering of 11,000,000 shares of common stock at a public offering price of $14.00 per share.

Demand for synthetic opioids continues to witness a decline in North America. According to a new research from Persistence Market Research, the US$ 75 billion synthetic opioids market will grow at a sluggish 2.4% during the period 2016-2024.

The global pneumatic compression therapy market is expected to witness robust growth during the forecast period. This growth is expected to be primarily driven by increasing adoption of pneumatic compression sleeves and pumps and a growing awareness of pneumatic compression therapy in developing economies.

The University of Kentucky and ArtemiLife Inc. will collaborate on a clinical study using the extract of a medicinal plant grown in Kentucky to test for anti-cancer activity of Artemisia annua and to determine the recommended dose of Artemisia annua for future clinical trials.

Increasing healthcare expenditure on treatment of cardiovascular diseases continues to propel the demand for pressure guidewires in the world. Cardiovascular treatment procedures developed over the years have integrated the use of pressure guidewires for navigating through blood vessels or lesions.

In recent years, reports of deadly animal disease outbreaks have become more recurrent. These diseases are not only a threat to the existence of many wild species but also lead to substantial livestock losses.

The Global Virus Network (GVN), a coalition comprised of the world’s preeminent human and animal virologists from 53 Centers of Excellence and 10 Affiliates in 32 countries, announced that two of its Centers of Excellence, the Peter Doherty Institute for Infection and Immunity in Melbourne, Australia and the Rega Medical Research Institute of KU Leuven, Belgium,